ORBIMED ADVISORS LLC – Mirum Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$10.96M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+7.97%
quarter
Mirum Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +86.72% | 242.39K shares | 5.52M | $21.01 | 521.89K |
Q2 2022 | share | Increase | +935.19% | 252.5K shares | 4.84M | $19.46 | 279.5K |
Q1 2022 | share | Increase | 0.00% | 27K shares | 595K | $22.02 | 27K |
Q1 2020 | share | Decrease | -100.00% | -71.3K shares | -1.74M | $14 | 0 |
Q4 2019 | share | Increase | 0.00% | 71.3K shares | 1.74M | $24.52 | 71.3K |